| NCT ID | NCT04839003 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione IRCCS Policlinico San Matteo di Pavia |
| Condition | AL Amyloidosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2020-02-27 |
| Primary Completion | 2027-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2020-02-27 with a primary completion date of 2027-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this protocol is to generate a large registry of patients with AL amyloidosis.
Eligibility Criteria
Inclusion Criteria: 1. diagnosis of systemic AL amyloidosis; 2. treatment-naïve (pre-treatment data collected at participating center available for retrospective part); 3. age ≥18 years; 4. ability to understand and willingness to sign an informed consent (patients who already sign informed consent for clinical data to be used in retrospective analyses will be accepted); 5. planned (or ongoing) follow-up at participating center. Exclusion Criteria: 1. non-AL amyloidosis; 2. previous treatment for AL amyloidosis.
Frequently Asked Questions
Who can join the NCT04839003 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying AL Amyloidosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04839003 currently recruiting?
Yes, NCT04839003 is actively recruiting participants. Visit ClinicalTrials.gov or contact Fondazione IRCCS Policlinico San Matteo di Pavia to inquire about joining.
Where is the NCT04839003 trial being conducted?
This trial is being conducted at Pavia, Italy.
Who is sponsoring the NCT04839003 clinical trial?
NCT04839003 is sponsored by Fondazione IRCCS Policlinico San Matteo di Pavia. The trial plans to enroll 5,000 participants.